Hutchison China MediTech Ltd ADR buy Bank of America Co.
Start price
22.07.25
/
50%
€14.60
Target price
22.07.26
€23.95
Performance (%)
-35.96%
Price
08.06.26
€9.15
Summary
This prediction is currently active. The BUY prediction by Bank_of_America_Co_ for Hutchison China MediTech Ltd ADR is performing very badly with a performance of -35.96%. This prediction currently runs until 22.07.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hutchison China MediTech Ltd ADR | -5.670% | -5.670% |
| iShares Core DAX® | -2.195% | 0.670% |
| iShares Nasdaq 100 | -2.629% | 2.992% |
| iShares Nikkei 225® | -2.021% | 3.141% |
| iShares S&P 500 | -1.670% | 2.405% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Hutchison China MediTech Ltd ADR diskutieren
HUTCHMED (China) Limited Sponsored ADR (NASDAQ: HCM) had its price target raised by analysts at Bank of America Corporation from $27.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for HCM provided by MarketBeat
Stopped prediction by Bank_of_America_Co_ for Hutchison China MediTech Ltd ADR
Hutchison China MediTech Ltd ADR
Start price
Target price
Perf. (%)
€11.90
10.03.26
10.03.26
€17.20
10.03.27
10.03.27
-21.43%
08.06.26
08.06.26
